Ardelyx, Inc. develops minimally absorbed small molecule drugs. The Company offers pharmaceuticals to correct mineral metabolism imbalance and metabolic disorders by modulating the function of specific transporters, channels, and receptors located on the epithelia of the gastrointestinal tract.
more
Refresh
Request Primer
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.